Sherwin-Williams reported slightly increased sales but faced decreased profits due to higher raw material costs and impairments. However, management reaffirmed full-year guidance and announced additional price increases to offset rising costs. The resolution of the lead pigment litigation removes a significant overhang, potentially boosting investor confidence in the short term.

[1]